Sutro Biopharma, Inc. (STRO) Social Stream
SUTRO BIOPHARMA INC (STRO) Price Targets From Analysts
Use the tables below to see what analysts covering SUTRO BIOPHARMA INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 6 | $37 | $29 | $34.2 | $4.99 | 585.37% |
| 2021-12-05 | 7 | $37 | $29 | $33.5 | $4.99 | 571.34% |
| 2022-05-09 | 7 | $37 | $29 | $32.333 | $4.99 | 547.96% |
| 2022-05-10 | 7 | $37 | $20 | $30.666 | $4.99 | 514.55% |
| 2022-05-11 | 7 | $37 | $20 | $29.833 | $4.99 | 497.86% |
| 2022-05-23 | 7 | $37 | $14 | $26.285 | $4.99 | 426.75% |
| 2022-08-10 | 7 | $37 | $16 | $26.571 | $4.99 | 432.48% |
| 2022-08-18 | 8 | $37 | $15 | $25.125 | $4.99 | 403.51% |
| 2022-11-09 | 8 | $33 | $15 | $21.875 | $4.99 | 338.38% |
| 2023-01-10 | 7 | $33 | $15 | $21 | $4.99 | 320.84% |
| 2023-01-13 | 7 | $33 | $15 | $21.571 | $4.99 | 332.28% |
| 2023-03-31 | 7 | $33 | $8 | $20.571 | $4.99 | 312.24% |
| 2023-05-16 | 8 | $25 | $8 | $18.428 | $4.99 | 269.3% |
| 2023-05-23 | 8 | $25 | $8 | $17.714 | $4.99 | 254.99% |
The Trend in the Analyst Price Target
STRO's average price target has moved down $16.49 over the prior 19 months.
Over the past 44 weeks, STRO's average upside potential has been 251.07%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-10 | 7 | 37 | 16 | 26.571 | 6.73 | 294.81% |
| 2022-08-18 | 8 | 37 | 15 | 25.125 | 6.64 | 278.39% |
| 2022-11-09 | 6 | 33 | 15 | 23.125 | 7.34 | 215.05% |
| 2023-03-31 | 8 | 33 | 8 | 20.000 | 4.62 | 332.9% |
| 2023-05-15 | 8 | 25 | 8 | 18.428 | 5.88 | 213.4% |
STRO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 7 | 0 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
STRO's average broker recommendation rating worsened by 0.25 over the prior 31 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for STRO as an investment opportunity.
- In terms of how SUTRO BIOPHARMA INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1827.09% of that group.
- To contextualize these metrics, consider that out of all US stocks, SUTRO BIOPHARMA INC's variance in analysts' estimates is lower than -1346.94% of them.
- STRO has a higher number of analysts covering the stock than 1707.82% of stocks in the small market cap category.
- In terms of how SUTRO BIOPHARMA INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1255.7% of that group.
In the Pharmaceutical Products industry, SURF, CLLS, and ADAP are the three stocks most similar to SUTRO BIOPHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is STRO a Buy, Hold or Sell? See the POWR Ratings now!